Cizzle Biotechnology Holdings Plc reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was GBP 0.912 million compared to GBP 3.92 million a year ago. Basic loss per share from continuing operations was GBP 0.003 compared to GBP 0.024 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 GBX | 0.00% | +6.25% | -12.82% |
Jun. 17 | Cizzle says CIZ1B biomarker test picked for "major" US cancer study | AN |
Apr. 30 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.82% | 8.51M | |
+21.60% | 46.93B | |
+37.63% | 39.08B | |
-8.37% | 38.48B | |
+28.96% | 31.01B | |
-13.75% | 26.14B | |
+11.16% | 25.88B | |
+36.31% | 12.53B | |
-6.49% | 11.36B | |
-12.31% | 10.65B |
- Stock Market
- Equities
- PSL Stock
- News Cizzle Biotechnology Holdings Plc
- Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Full Year Ended December 31, 2022